Vivos Therapeutics (VVOS) Total Liabilities (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Total Liabilities of $26.3 million for Q1 2026, up 282.55% year-over-year from $6.9 million in Q1 2025, and down 1.51% quarter-over-quarter from $26.7 million in Q4 2025.
Vivos Therapeutics (VVOS) Total Liabilities (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Total Liabilities for 8 consecutive years, with $26.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 282.55% year-over-year to $26.3 million; the TTM figure through Mar 2026 stood at $26.3 million (up 282.55% YoY), while the FY2025 annual figure was $26.7 million, up 264.28% from the prior year.
- Total Liabilities declined to $26.3 million in Q1 2026 per VVOS's latest filing, from $26.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $26.7 million in Q4 2025 and bottomed at $6.9 million in Q1 2025.
- Historically, Total Liabilities has averaged $12.8 million across 5 years, with a median of $10.1 million in 2023.
- Annual changes were most pronounced in 2025 — Total Liabilities tumbled 38.62% — and 2026, when it jumped 282.55%.
- Vivos Therapeutics' Total Liabilities stood at $8.9 million in 2022, then gained by 15.7% to $10.3 million in 2023, then declined by 28.97% to $7.3 million in 2024, then soared by 264.28% to $26.7 million in 2025, then declined by 1.51% to $26.3 million in 2026.
- Business Quant data shows VVOS's Total Liabilities at $26.3 million in Q1 2026, $26.7 million in Q4 2025, and $23.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 28.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.30 Mn |
| Dec 31, 2025 | 26.70 Mn |
| Sep 30, 2025 | 23.11 Mn |
| Jun 30, 2025 | 21.50 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 7.33 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 9.50 Mn |
| Mar 31, 2024 | 11.20 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | 10.27 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 8.92 Mn |
| Sep 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 9.54 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 8.15 Mn |
| Sep 30, 2021 | 8.56 Mn |
| Jun 30, 2021 | 9.67 Mn |